Announced Mon, 20 Jul · 14:53 IST
Ajanta Pharma Q1 FY27 earnings call on 30 July 2026
Board & Shareholder Meetings View source PDF
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.8%1-day move
₹3410.00
prior close
₹3466.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.0-0.0+0.0+4.8+1.2+0.6-1.1-0.7—————
Up moveDown movePending
AI summary
Ajanta Pharma will announce its Q1 FY2027 unaudited financial results on 30 July 2026, after a Board meeting. An earnings conference call follows at 16:30 hrs IST where the leadership team will discuss performance and take questions. Dial-in numbers and a Diamond Pass registration link are provided for investors. A call transcript will be posted on the company's website.
Likely market impact
Signals upcoming Q1 results and management commentary; watch for guidance updates that could move the stock.